Cannabidiol Research

I am constantly trying to ride the higher high. So when I get e-mails like this one, I pay attention. It could be the difference between smoking the ‘pretendica’ or the actual real deal. Thanks to the Great Eugene Davidovich for passing this along:

Dear Medical Cannabis Collectives, Patients, Physicians and Friends:

As you may know, Cannabidiol (CBD) is a non-psychoactive compound

in marijuana that has significant medical benefits. In addition to

having anti-inflammatory, anti-pain, anti-psychotic and

anti-spasmodic effects, CBD has unique benefits in reducing adverse

psychological effects of THC, such as anxiety, confusion, paranoia,

and memory loss, which can be problematic to many patients, such as

the elderly. Clinical studies have shown that patients report more

medical relief from strains with an equal mixture of CBD and THC to

those with just THC or CBD alone.

Until recently, CBD has not been readily available on the market.

Laboratory surveys have found that the vast majority of available

strains have only insignificant traces of CBD. Only recently, with

the arrival of labs willing to analyze cannabis samples, has it

become possible to identify and develop CBD-rich strains for

practical medical use. More than 25 CBD-rich strains have been

identified and are now being grown out for use by patients in

California and beyond. The Society of Cannabis Clinicians has

developed a survey to document the effects of these strains.

Attached is an invitation to partner with ProjectCBD.org. I hope

that your collective will make the most of this unique opportunity.

Support for Project CBD will enhance the credibility of your

collective and the medical cannabis industry as a whole.

Dale Gieringer, Ph.D.

Director, Cal NORML

Dear Dispensing Collective,

ProjectCBD is the leading resource for doctors and patients seeking

information about Cannabidiol and CBD-rich cannabis. ProjectCBD.org

features a Society of Cannabis Clinicians survey designed to evaluate

patient responses to CBD-rich medicine. We are confident that a

serious, professional, physician-run data-collection effort will

enhance the credibility of the medical cannabis movement.

This is to request that you notify us when making CBD-rich medicine

available to patients. We look forward to acknowledging you at

ProjectCBD.org/CBDiary.html

We also request that you support us by becoming a participating

dispensary. The fee is $150 to $750 per quarter, based on ability to

pay. News coverage is not contingent on participation and people

unable to pay are not expected to. Benefits for participating

dispensaries include:

* Priority access to CBD-rich cannabis -including genetics when available

* Logo/listing on projectcbd.org as a participating collective

* Materials for educating patients and staff about the potential of CBD

* Speaker(s) for public forums and meetings with government agencies

* Validation of your collective’s medical identity and purpose.

For more information,

visit <http://www.projectcbd.org>www.projectcbd.org and/or contact me

directly.

Sincerely,

Sarah Russo

Project CBD Outreach Coordinator

<mailto:sarahrusso@projectcbd.org>sarahrusso@projectcbd.org

707-581-1818